QuidelOrtho Corporation logo QDEL - QuidelOrtho Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 6
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $12.25 DETAILS
HIGH: $12.50
LOW: $12.00
MEDIAN: $12.25
CONSENSUS: $12.25
UPSIDE: 0.29%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Distressed or Transitioning 75% confidence

Primary model: Current EPS × Depressed Multiple

Valuation Signal Undervalued Strong
Trading 78.5% below fair value
Current Price $12.21
Bear Case $37.89 210.2% upside ($37.89 - $12.21) / $12.21 = 210.2% EPS continues to decline, 5x multiple
Fair Value $56.84 365.3% upside ($56.84 - $12.21) / $12.21 = 365.3% Current EPS stabilizes, 8x multiple
Bull Case $75.78 520.4% upside ($75.78 - $12.21) / $12.21 = 520.4% Credible recovery, multiple re-rates to 10x

Adjust Assumptions

7.5x

Key Value Driver

Whether the core business model is intact or structurally impaired

Implied Market Multiple 1.3x

Plain-Language Summary

Our base-case estimate uses Current EPS × Depressed Multiple. We then blend that result with the average analyst price target of $12.25 from 15 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $56.84 per share.

Warnings

Don't assume past cash flow levels will return — the company's troubles may have permanently reduced its ability to generate profits.
A stock can look cheap on paper and still lose half its value if the underlying business is permanently damaged.
The wide range between our best and worst cases is intentional — pretending to know a precise value for a troubled company would be misleading.
Debt per share ($38.16) is more than half the stock price. With this much debt on a struggling business, the paths to recovery for shareholders are narrow.
Wall Street's average price target is $12.25 (from 15 analysts). Our estimate is 485% above the consensus -- consider that gap carefully.

Key Risks

  • Bullish DCF projections are fundamentally unknowable for distressed companies
  • M&A speculation can floor the stock above intrinsic value temporarily
  • Management credibility is a key input — new CEO expands the bull case